GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » EV-to-Revenue

Touyun Biotech Group (HKSE:01332) EV-to-Revenue : 5.01 (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Touyun Biotech Group's enterprise value is HK$994.2 Mil. Touyun Biotech Group's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$198.6 Mil. Therefore, Touyun Biotech Group's EV-to-Revenue for today is 5.01.

The historical rank and industry rank for Touyun Biotech Group's EV-to-Revenue or its related term are showing as below:

HKSE:01332' s EV-to-Revenue Range Over the Past 10 Years
Min: -78.91   Med: 3.01   Max: 21.11
Current: 5.01

During the past 13 years, the highest EV-to-Revenue of Touyun Biotech Group was 21.11. The lowest was -78.91. And the median was 3.01.

HKSE:01332's EV-to-Revenue is ranked worse than
94.01% of 384 companies
in the Packaging & Containers industry
Industry Median: 1.06 vs HKSE:01332: 5.01

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), Touyun Biotech Group's stock price is HK$0.23. Touyun Biotech Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.07. Therefore, Touyun Biotech Group's PS Ratio for today is 3.24.


Touyun Biotech Group EV-to-Revenue Historical Data

The historical data trend for Touyun Biotech Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group EV-to-Revenue Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.83 10.23 13.92 4.68 5.12

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.92 - 4.68 - -

Competitive Comparison of Touyun Biotech Group's EV-to-Revenue

For the Packaging & Containers subindustry, Touyun Biotech Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group's EV-to-Revenue Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's EV-to-Revenue falls into.



Touyun Biotech Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Touyun Biotech Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=994.242/198.64
=5.01

Touyun Biotech Group's current Enterprise Value is HK$994.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Touyun Biotech Group's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$198.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group  (HKSE:01332) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Touyun Biotech Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.23/0.071
=3.24

Touyun Biotech Group's share price for today is HK$0.23.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines